EDN1 and colorectal cancer: Collectively, these findings demonstrate that oxaliplatin-induced overexpression of EDN1 promotes the nuclear translocation of β-arr1, thereby facilitating the activation of YAP signaling and contributing to chemoresistance in colorectal cancer.